Nicholas J Douville1, Ida Surakka2, Aleda Leis1, Christopher B Douville3,4,5, Whitney E Hornsby6, Chad M Brummett1, Sachin Kheterpal1, Cristen J Willer6,7,8, Milo Engoren1, Michael R Mathis1. 1. Department of Anesthesiology, Michigan Medicine, Ann Arbor (N.J.D., A.L., C.M.B., S.K., M.E., M.R.M.). 2. Division of Cardiovascular Medicine, Department of Internal Medicine (I.S.), University of Michigan, Ann Arbor. 3. Ludwig Center for Cancer Genetics and Therapeutics (C.B.D.), Johns Hopkins University School of Medicine, Baltimore, MD. 4. Sidney Kimmel Cancer Center (C.B.D.), Johns Hopkins University School of Medicine, Baltimore, MD. 5. Sol Goldman Pancreatic Cancer Research Center (C.B.D.), Johns Hopkins University School of Medicine, Baltimore, MD. 6. Department of Internal Medicine (W.E.H., C.J.W.), University of Michigan, Ann Arbor. 7. Department of Computational Medicine and Bioinformatics (C.J.W.), University of Michigan, Ann Arbor. 8. Department of Human Genetics (C.J.W.), University of Michigan, Ann Arbor.
Abstract
BACKGROUND: While postoperative myocardial injury remains a major driver of morbidity and mortality, the ability to accurately identify patients at risk remains limited despite decades of clinical research. The role of genetic information in predicting myocardial injury after noncardiac surgery (MINS) remains unknown and requires large scale electronic health record and genomic data sets. METHODS: In this retrospective observational study of adult patients undergoing noncardiac surgery, we defined MINS as new troponin elevation within 30 days following surgery. To determine the incremental value of polygenic risk score (PRS) for coronary artery disease, we added the score to 3 models of MINS risk: revised cardiac risk index, a model comprised entirely of preoperative variables, and a model with combined preoperative plus intraoperative variables. We assessed performance without and with PRSs via area under the receiver operating characteristic curve and net reclassification index. RESULTS: Among 90 053 procedures across 40 498 genotyped individuals, we observed 429 cases with MINS (0.5%). PRS for coronary artery disease was independently associated with MINS for each multivariable model created (odds ratio=1.12 [95% CI, 1.02-1.24], P=0.023 in the revised cardiac risk index-based model; odds ratio, 1.19 [95% CI, 1.07-1.31], P=0.001 in the preoperative model; and odds ratio, 1.17 [95% CI, 1.06-1.30], P=0.003 in the preoperative plus intraoperative model). The addition of clinical risk factors improved model discrimination. When PRS was included with preoperative and preoperative plus intraoperative models, up to 3.6% of procedures were shifted into a new outcome classification. CONCLUSIONS: The addition of a PRS does not significantly improve discrimination but remains independently associated with MINS and improves goodness of fit. As genetic analysis becomes more common, clinicians will have an opportunity to use polygenic risk to predict perioperative complications. Further studies are necessary to determine if PRSs can inform MINS surveillance.
BACKGROUND: While postoperative myocardial injury remains a major driver of morbidity and mortality, the ability to accurately identify patients at risk remains limited despite decades of clinical research. The role of genetic information in predicting myocardial injury after noncardiac surgery (MINS) remains unknown and requires large scale electronic health record and genomic data sets. METHODS: In this retrospective observational study of adult patients undergoing noncardiac surgery, we defined MINS as new troponin elevation within 30 days following surgery. To determine the incremental value of polygenic risk score (PRS) for coronary artery disease, we added the score to 3 models of MINS risk: revised cardiac risk index, a model comprised entirely of preoperative variables, and a model with combined preoperative plus intraoperative variables. We assessed performance without and with PRSs via area under the receiver operating characteristic curve and net reclassification index. RESULTS: Among 90 053 procedures across 40 498 genotyped individuals, we observed 429 cases with MINS (0.5%). PRS for coronary artery disease was independently associated with MINS for each multivariable model created (odds ratio=1.12 [95% CI, 1.02-1.24], P=0.023 in the revised cardiac risk index-based model; odds ratio, 1.19 [95% CI, 1.07-1.31], P=0.001 in the preoperative model; and odds ratio, 1.17 [95% CI, 1.06-1.30], P=0.003 in the preoperative plus intraoperative model). The addition of clinical risk factors improved model discrimination. When PRS was included with preoperative and preoperative plus intraoperative models, up to 3.6% of procedures were shifted into a new outcome classification. CONCLUSIONS: The addition of a PRS does not significantly improve discrimination but remains independently associated with MINS and improves goodness of fit. As genetic analysis becomes more common, clinicians will have an opportunity to use polygenic risk to predict perioperative complications. Further studies are necessary to determine if PRSs can inform MINS surveillance.
Authors: T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman Journal: Circulation Date: 1999-09-07 Impact factor: 29.690
Authors: Sachin Kheterpal; Michael O'Reilly; Michael J Englesbe; Andrew L Rosenberg; Amy M Shanks; Lingling Zhang; Edward D Rothman; Darrell A Campbell; Kevin K Tremper Journal: Anesthesiology Date: 2009-01 Impact factor: 7.892
Authors: T Sheth; M K Natarajan; V Hsieh; N Valettas; M Rokoss; S Mehta; S Jolly; V Tandon; H Bezerra; P J Devereaux Journal: Br J Anaesth Date: 2017-11-21 Impact factor: 9.166
Authors: W Lane Duvall; Brett Sealove; Chetan Pungoti; Daniel Katz; Pedro Moreno; Michael Kim Journal: Catheter Cardiovasc Interv Date: 2012-03-14 Impact factor: 2.692
Authors: Amit V Khera; Mark Chaffin; Krishna G Aragam; Mary E Haas; Carolina Roselli; Seung Hoan Choi; Pradeep Natarajan; Eric S Lander; Steven A Lubitz; Patrick T Ellinor; Sekar Kathiresan Journal: Nat Genet Date: 2018-08-13 Impact factor: 38.330
Authors: Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen Journal: Cochrane Database Syst Rev Date: 2021-12-21
Authors: Adam Lewis; Lisa Bastarache; Anita Pandit; Daniel B Larach; Jing He; Anik Sinha; Nicholas J Douville; Michael Heung; Michael R Mathis; Jonathan D Mosley; Jonathan P Wanderer; Sachin Kheterpal; Matthew Zawistowski; Chad M Brummett; Edward D Siew; Cassianne Robinson-Cohen; Miklos D Kertai Journal: BMC Nephrol Date: 2022-10-21 Impact factor: 2.585
Authors: Nicholas J Douville; Sachin Kheterpal; Milo Engoren; Michael Mathis; George A Mashour; Whitney E Hornsby; Cristen J Willer; Christopher B Douville Journal: Br J Anaesth Date: 2020-09-03 Impact factor: 9.166